NCT01484691
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Hypersensitivity, Immediate
Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.
6,751 public trials
635 recruiting studies
Hypersensitivity, Immediate trial results
NCT03871998
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
- Locations
-
- Cork University Maternity Hospital Cork, Ireland
Completed
The Asthma Breathing Record Study
NCT04504838
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Portsmouth Hospitals NHS Trust Portsmouth, Hampshire, United Kingdom
NCT03387852
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Investigational Site Number 8400026 Birmingham, Alabama, United States
- Investigational Site Number 8400004 Long Beach, California, United States
- Investigational Site Number 8400020 Los Angeles, California, United States
- Investigational Site Number 8400001 Rolling Hills Estates, California, United States
NCT03337802
- Conditions
- Food Allergy, Food Hypersensitivity, Hypersensitivity, +2 more
- Locations
-
- University of Naples Federico II Naples, Italy
NCT04360187
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
- Locations
-
- Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
- Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
- Guangzhou First People's Hospital Guangzhou, Guangdong, China
- The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
NCT01913795
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
Completed
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
NCT04450108
- Conditions
- Asthma, Asthma in Children, Bronchial Diseases, +7 more
- Locations
-
- Clinical Research Center of Alabama Birmingham, Alabama, United States
- Kern Research, Inc. Bakersfield, California, United States
- Chesapeake Clinical Research, Inc. White Marsh, Maryland, United States
- The Clinical Research Center, LLC St Louis, Missouri, United States
Completed
Long-term Safety of Tezepelumab in Japanese Subjects With Inadequately Controlled Severe Asthma
NCT04048343
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +7 more
- Locations
-
- Research Site Chūōku, Japan
- Research Site Chūōku, Japan
- Research Site Sagamihara-shi, Japan
- Research Site Shinagawa-ku, Japan
NCT01092143
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- 1268.17.01043 Boehringer Ingelheim Investigational Site Tucson, Arizona, United States
- 1268.17.01009 Boehringer Ingelheim Investigational Site Cypress, California, United States
- 1268.17.01006 Boehringer Ingelheim Investigational Site Los Angeles, California, United States
- 1268.17.01040 Boehringer Ingelheim Investigational Site Palmdale, California, United States